Comparative understanding of UTS2 and UTS2R genes for their involvement in type 2 diabetes mellitus

Several reports have shown that urotensin 2 (UTS2) and its receptor (UTS2R) are involved in glucose metabolism and insulin resistance, which lead to development of type 2 diabetes mellitus (T2DM) in humans. In the present study, we annotated both bovine UTS2 and UTS2R genes and identified 5 single nucleotide polymorphisms (SNPs) for the former gene and 14 mutations for the latter gene. Four mutations were genotyped on a Wagyu x Limousin reference population, including 6 F1 bulls, 113 F1 dams and ~250 F2 progeny. Among 12 phenotypes related to fat deposition and fatty acid composition, we observed that the UTS2 gene was significantly associated with the amount of skeletal saturated fatty acids, while its receptor (UTS2R) gene had significant effects on amounts of saturated and monounsaturated fatty acids, Δ9 desaturase activity for converting 16:0 into 16:1, muscle fat (marbling) score and Longissimus Dorsi muscle area. However, in this population, these markers were not associated with subcutaneous fat depth or percent kidney, pelvic and heart fat. We also found that mutations in the promoter regions altered the promoter activities in both genes and coding SNPs might affect the mRNA stability in the UTS2R gene. Overall, our present study provides the first evidence that both UTS2 and UTS2R genes regulate skeletal muscle fat accumulation and fatty acid metabolism, thus indicating their potential pathological functions related to obesity and T2DM in humans.

[1]  T. Werner,et al.  MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. , 1995, Nucleic acids research.

[2]  You-Qiang Song,et al.  Haplotypes in the urotensin II gene and urotensin II receptor gene are associated with insulin resistance and impaired glucose tolerance , 2006, Peptides.

[3]  Shana Suzuki,et al.  Enhanced muscle by myostatin propeptide increases adipose tissue adiponectin, PPAR-alpha, and PPAR-gamma expressions. , 2008, Biochemical and biophysical research communications.

[4]  S. Lillioja,et al.  Skeletal Muscle Triglyceride Levels Are Inversely Related to Insulin Action , 1997, Diabetes.

[5]  P. McKeigue,et al.  Relation of triglyceride stores in skeletal muscle cells to central obesity and insulin sensitivity in European and South Asian men , 1999, Diabetologia.

[6]  Yuan Zhang,et al.  Increased expression of urotensin II and urotensin II receptor in human diabetic nephropathy. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[7]  N. Aiyar,et al.  Molecular and pharmacological characterization of genes encoding urotensin‐II peptides and their cognate G‐protein‐coupled receptors from the mouse and monkey , 2002, British journal of pharmacology.

[8]  R. Nishioka,et al.  Neurohormones from fish tails: the caudal neurosecretory system. I. "Urophysiology" and the caudal neurosecretory system of fishes. , 1985, Recent progress in hormone research.

[9]  H. Vaudry,et al.  Urotensin-II is present in pancreatic extracts and inhibits insulin release in the perfused rat pancreas. , 2004, European journal of endocrinology.

[10]  H. Heng,et al.  Cloning and chromosomal mapping of three novel genes, GPR9, GPR10, and GPR14, encoding receptors related to interleukin 8, neuropeptide Y, and somatostatin receptors. , 1995, Genomics.

[11]  T. Kunej,et al.  Cross Species Association Examination of UCN3 and CRHR2 as Potential Pharmacological Targets for Antiobesity Drugs , 2006, PloS one.

[12]  H. Sarau,et al.  Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14 , 1999, Nature.

[13]  Michael Zuker,et al.  Mfold web server for nucleic acid folding and hybridization prediction , 2003, Nucleic Acids Res..

[14]  Karen Willcox,et al.  Kinetics and kinematics for translational motions in microgravity during parabolic flight. , 2009, Aviation, space, and environmental medicine.

[15]  Nobuyuki Miyajima,et al.  Identification of urotensin II-related peptide as the urotensin II-immunoreactive molecule in the rat brain. , 2003, Biochemical and biophysical research communications.

[16]  B. Goodpaster,et al.  Skeletal muscle lipid accumulation in obesity, insulin resistance, and type 2 diabetes , 2004, Pediatric diabetes.

[17]  T. Kunej,et al.  Significant associations of the mitochondrial transcription factor A promoter polymorphisms with marbling and subcutaneous fat depth in Wagyu x Limousin F2 crosses. , 2005, Biochemical and biophysical research communications.

[18]  M. Clozel,et al.  The Urotensin-II Receptor Antagonist Palosuran Improves Pancreatic and Renal Function in Diabetic Rats , 2006, Journal of Pharmacology and Experimental Therapeutics.

[19]  B. Cheung,et al.  The role of urotensin II in the metabolic syndrome , 2008, Peptides.

[20]  L. Alexander,et al.  Quantitative trait loci with additive effects on palatability and fatty acid composition of meat in a Wagyu-Limousin F2 population. , 2007, Animal genetics.